EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseStudienprotokollOpen Access · CC BY-NC 4.0

What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis

C A Venetis iD, A Storr, S J Chua iD, B W Mol iD, S Longobardi, X Yin, T D'Hooghe iD

Human Reproduction Update · 02.05.2023 · 29 (3) · 307-326

DOI: 10.1093/humupd/dmac040 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Human Reproduction Update, online erschienen am 03.01.2023. Verfasst von C A Venetis und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of New South Wales, Faculty of Medicine & Health, Centre for Big Data Research in Health & Discipline of Obstetrics and Gynaecology, Sydne…. Hauptthemen laut MEDLINE: Ovulation Induction, Ovarian Hyperstimulation Syndrome. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Merck, NHMRC Early Career Fellowship, NHMRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Several GnRH antagonist protocols are currently used during COS in the context of ART treatments; however, questions remain regarding whether these protocols are comparable in terms of efficacy and safety. OBJECTIVE AND RATIONALE A systematic review followed by a pairwise and network meta-analyses were performed. The systematic review and pairwise meta-analysis of direct comparative data according to the PRISMA guidelines evaluated the effectiveness of different GnRH antagonist protocols (fixed Day 5/6 versus flexible, ganirelix versus cetrorelix, with or without hormonal pretreatment) on the probability of live birth and ongoing pregnancy after COS during ART treatment. A frequentist network meta-analysis combining direct and indirect comparisons (using the long GnRH agonist protocol as the comparator) was also performed to enhance the precision of the estimates. SEARCH METHODS The systematic literature search was performed using Embase (Ovid), MEDLINE (Ovid), Cochrane Central Register of Trials (CENTRAL), SCOPUS and Web of Science (WOS), from inception until 23 November 2021. The search terms comprised three different MeSH terms that should be present in the identified studies: GnRH antagonist; assisted reproduction treatment; randomized controlled trial (RCT). Only studies published in English were included. OUTCOMES The search strategy resulted in 6738 individual publications, of which 102 were included in the systematic review (corresponding to 75 unique studies) and 73 were included in the meta-analysis. Most studies were of low quality. One study compared a flexible protocol with a fixed Day 5 protocol and the remaining RCTs with a fixed Day 6 protocol. There was a lack of data regarding live birth when comparing the flexible and fixed GnRH antagonist protocols or cetrorelix and ganirelix. No significant difference in live birth rate was observed between the different pretreatment regimens versus no pretreatment or between the different pretreatment protocols. A flexible GnRH antagonist protocol resulted in a significantly lower OPR compared with a fixed Day 5/6 protocol (relative risk (RR) 0.76, 95% CI 0.62 to 0.94, I2 = 0%; 6 RCTs; n = 907 participants; low certainty evidence). There were insufficient data for a comparison of cetrorelix and ganirelix for OPR. OCP pretreatment was associated with a lower OPR compared with no pretreatment intervention (RR 0.79, 95% CI 0.69 to 0.92; I2 = 0%; 5 RCTs, n = 1318 participants; low certainty evidence). Furthermore, in the network meta-analysis, a fixed protocol with OCP resulted in a significantly lower OPR than a fixed protocol with no pretreatment (RR 0.84, 95% CI 0.71 to 0.99; moderate quality evidence). The surface under the cumulative ranking (SUCRA) scores suggested that the fixed protocol with no pretreatment is the antagonist protocol most likely (84%) to result in the highest OPR. There was insufficient evidence of a difference between fixed/flexible or OCP pretreatment/no pretreatment interventions regarding other outcomes, such as ovarian hyperstimulation syndrome and miscarriage rates. WIDER IMPLICATIONS Available evidence, mostly of low quality and certainty, suggests that different antagonist protocols should not be considered as equivalent for clinical decision-making. More trials are required to assess the comparative effectiveness of ganirelix versus cetrorelix, the effect of different pretreatment interventions (e.g. progestins or oestradiol) or the effect of different criteria for initiation of the antagonist in the flexible protocol. Furthermore, more studies are required examining the optimal GnRH antagonist protocol in women with high or low response to ovarian stimulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovulation InductionOvarian Hyperstimulation SyndromePregnancyFemaleHumansPregnancy RateGonadotropin-Releasing HormoneSystematic Reviews as TopicNetwork Meta-Analysis as Topic

Stichwörter der Autor:innen

ARTGnRH antagonistassisted reproductive technologiescetrorelixcontrolled ovarian stimulationganirelixlive birthpregnancy

Substanzen

Gonadotropin-Releasing Hormone

Autor:innen und Institutionen

  • University of New South Wales, Faculty of Medicine & Health, Centre for Big Data Research in Health & Discipline of Obstetrics and Gynaecology, Sydney, Australia.
  • IVFAustralia, Alexandria, NSW, Australia.
  • Flinders Fertility, Adelaide, SA, Australia.
  • College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
  • Austin Health, Heidelberg, Australia.
  • Department of Obstetrics and Gynaecology, Monash University, Clayton, Australia.

ORCID-Profile: C A Venetis, S J Chua, B W Mol, T D'Hooghe

Förderung

  • Merck
  • NHMRC Early Career Fellowship
  • NHMRC

Zitieren

APA

Venetis, C. A., Storr, A., Chua, S. J., Mol, B. W., Longobardi, S., Yin, X., & D'Hooghe, T. (2023). What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis. Human Reproduction Update, 29(3), 307-326. https://doi.org/10.1093/humupd/dmac040

Vancouver

Venetis CA, Storr A, Chua SJ, Mol BW, Longobardi S, Yin X, et al. What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis. Human Reproduction Update. 2023;29(3):307-326. doi:10.1093/humupd/dmac040

BibTeX
@article{Venetis2023,
  author = {Venetis, C A and Storr, A and Chua, S J and Mol, B W and Longobardi, S and Yin, X and D'Hooghe, T},
  title = {What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis},
  journal = {Human Reproduction Update},
  year = {2023},
  volume = {29},
  number = {3},
  pages = {307--326},
  doi = {10.1093/humupd/dmac040}
}
Kostenlos starten →